Our next Webcast is coming soon—keep an eye out for details on the topic, speakers, and registration. Don’t miss your chance to gain expert perspectives on the key issues shaping the legal industry.
Immunovant, Inc. announced it will host an investor webcast on March 19, 2025, at 8:00 a.m. ET to discuss results from its Phase 3 study of batoclimab for myasthenia gravis and initial findings from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback